Neuromuscular	neuromuscular	O	B_disease
blockade	blockade	O	I_disease
with	with	O	O
magnesium	magnesium	B_chemicals	O
sulfate	sulfate	S_chemicals	O
and	and	O	O
nifedipine	nifedipine	O	O
.	.	O	O

A	a	O	O
patient	patient	O	O
who	who	O	O
received	received	O	O
tocolysis	tocolysis	O	O
with	with	O	O
nifedipine	nifedipine	O	O
developed	developed	O	O
neuromuscular	neuromuscular	O	B_disease
blockade	blockade	O	I_disease
after	after	O	O
500	500	O	O
mg	mg	O	O
of	of	O	O
magnesium	magnesium	B_chemicals	O
sulfate	sulfate	S_chemicals	O
was	was	O	O
administered	administered	O	O
.	.	O	O

This	this	O	O
reaction	reaction	O	O
demonstrates	demonstrates	O	O
that	that	O	O
nifedipine	nifedipine	O	O
can	can	O	O
seriously	seriously	O	O
potentiate	potentiate	O	O
the	the	O	O
toxicity	toxicity	O	O
of	of	O	O
magnesium	magnesium	O	O
.	.	O	O

Caution	caution	O	O
should	should	O	O
be	be	O	O
exercised	exercised	O	O
when	when	O	O
these	these	O	O
two	two	O	O
tocolytics	tocolytics	S_chemicals	O
are	are	O	O
combined	combined	O	O
.	.	O	O

